BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Akesis Pharmaceuticals 



La Jolla  California    U.S.A.
Phone: n/a Fax:


SEARCH JOBS


Industry
Pharmaceutical






 Company News
Akesis Pharmaceuticals Discontinues Sole Clinical Development Program and Announces Intent to File for Chapter 7 Bankruptcy 1/22/2009 6:46:08 AM    More...
Akesis Pharmaceuticals Announces Pipeline Expansion Strategy 11/6/2008 11:16:20 AM    More...
Akesis Pharmaceuticals Appoints Carl LeBel as CEO and Jay Lichter as Executive Chairman 11/5/2008 6:45:13 AM    More...
Akesis Pharmaceuticals Enters into Bridge Financing Transaction 9/30/2008 8:51:37 AM    More...
Akesis Pharmaceuticals Expands Preclinical Safety Program for Lead Product 9/22/2008 9:50:54 AM    More...
Akesis Pharmaceuticals Names Christos Mantzoros, MD, DSc to its Scientific Advisory Board 7/18/2008 10:18:33 AM    More...
Akesis Pharmaceuticals Names Carl LeBel as President and Chief Operating Officer 6/30/2008 9:47:24 AM    More...
Akesis Pharmaceuticals and Charles River Laboratories (Massachusetts) to Begin 13-Week Animal Study for AKP- 020 6/24/2008 9:55:52 AM    More...
Akesis Pharmaceuticals Reports Positive Results from its Phase IIa Trial of AKP-020 for Type 2 Diabetes 6/17/2008 6:37:33 AM    More...
Akesis Pharmaceuticals Completes Phase IIa Trial of AKP-020 for Type 2 Diabetes 6/4/2008 9:53:04 AM    More...
1234

//-->